ANNEX A - STANDARDISED DISCLOSURE TEMPLATE

Date of publication : 28 June 2024

Contribution to costs of Events

Fee for service and consultancy

HCPs: City of Principal

Related expenses

Unique Country

Donations and

Sponsorship

agreed in the fee for

TOTAL

Practice

service or

Full name

Country of Principal Practice

Principal Practice Address

identifier

agreements with

HCOs: city where

Grants to HCOs

consultancy

OPTIONAL

OPTIONAL

HCOs / third

Travel &

regeistered

Registration Fees

Fees

contract; including

parties appointed

Accommodcation

by HCOs to

travel &

accommodation

manage an event

relevant to the

contract

INDIVIDUAL NAMED DISCLOSURE - one line per HCP (i.e. all transfers of value during a year for an individual HCP will be summed up : itemization should be available for the individual Recipient or public authorities' consultation only, as appropriate)

Dr Frédéric Dadoun

1210 Rollengergronn-Be

Grand Duché du Luxembourg

4, Rue E. Barblé

/

NA

NA

888,99

1.187,24

0,00

0,00

2.076,23

Dr Catherine Atlan

1210 Rollengergronn-Be

Grand Duché du Luxembourg

4, Rue E. Barblé

/

NA

NA

617,00

1.732,61

0,00

0,00

2.349,61

Dr. Luc Frankart

2540 Luxembourg

Grand Duché du Luxembourg

9, Rue Edward Steichen

/

NA

NA

209,91

918,42

0,00

0,00

1.128,33

Prof. Dr. Michael Heneka

4367 Belvaux

Grand Duché du Luxembourg

6, Avenue du swing

/

NA

NA

800,00

0,00

4.537,00

606,58

5.943,58

HCPs

OTHER, NOT INCLUDED ABOVE - where information cannot be disclosed in an individual basis for legal reasons

Aggregate amount attributable to transfers of value to such Recipients

NA

NA

2.737,69

7.332,70

0,00

0,00

10.070,39

Number of Recipients in aggregate disclosure

NA

NA

4

5

0

0

NA

% of the number of Recipients included in the aggregate disclosure in the total number, by category, of Recipients disclosed

NA

NA

50

56

0

0

NA

INDIVIDUAL NAMED DISCLOSURE - one line per HCO (I.e. all transfers of value during a year for an individual HCO will be summed up ; itemization should be available for the individual Recipient or plublic authorities' consultation only, as appropriate)

Alzheimer Europe

1736 Senningerberg

Grand Duché du Luxembourg

5B, Heienhaff

0

25.000,00

0

0

262,50

0

Rehazenter

2674 Luxembourg

Grand Duché du Luxembourg

1, rue André Vésale

0

1.468,79

0

0

0

0

Société Luxembourgeoise de Cardiologie

1210 Luxembourg

Grand Duché du Luxembourg

2A Rue E. Barblé

0

7.000,00

0

0

0

0

Université du Luxembourg

4365 Esch-sur-Alzette

Grand Duché du Luxembourg

2, avenue de l'université

0

10.000,00

0

0

0

0

HCOs

Association Luxembourgesoise du Diabète

2168 Luxembourg

Grand Duché du Luxembourg

143, rue de Mülhenbach

0

500,00

0

0

0

0

OTHER, NOT INCLUDED ABOVE - where information cannot be disclosed on an individual basis for legal reasons

Aggregate amount attributable to transfers of value to such Recipients

0

0

0

0

0

0

Number of Recipients in aggregate disclosure

0

0

0

0

0

0

% of the number of Recipients included in the aggregate disclosure in the total number, by category, of Recipients disclosed

0

0

0

0

0

0

25.262,50

1.468,79

7.000,00

10.000,00

500,00

0

0

NA

R&D

AGGREGATE DISCLOSURE

Transfers of Value re Research & Development as defined in the EFPIA Code of Practice

7.203,98

NA

TOTAL

65.799,43

Attachments

Disclaimer

Novo Nordisk A/S published this content on 26 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 July 2024 22:05:05 UTC.